| Literature DB >> 30242160 |
Nirupa R Ghai1, Christopher D Jensen2, Douglas A Corley2, Chyke A Doubeni3, Joanne E Schottinger4, Ann G Zauber5, Alexander T Lee6, Richard Contreras7, Theodore R Levin8, Jeffrey K Lee2, Virginia P Quinn7.
Abstract
BACKGROUND: Screening reduces colorectal cancer deaths, but <50% of Asian Americans are screening up-to-date according to surveys, with variability across Asian subgroups. We examined colorectal cancer screening participation among Asian Americans overall and Asian subgroups in a large integrated health care system with organized screening.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30242160 PMCID: PMC6155113 DOI: 10.1038/s41424-018-0051-2
Source DB: PubMed Journal: Clin Transl Gastroenterol ISSN: 2155-384X Impact factor: 4.488
Demographic and clinical characteristics among Asian subgroups, Asians overall, and non-Hispanic whites
| Filipino | Chinese | Vietnamese | Asian Indian | Japanese | Korean | Other Asian | Asians Overall | NH Whites | Total | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total, n (%) | 30,201 (43.4) | 10,994 (15.8) | 7456 (10.7) | 6314 (9.1) | 4498 (6.5) | 4857 (7.0) | 5506 (7.9) | 69,826 (16.0) | 366,572 (84.0) | 436,398 (100) |
|
| ||||||||||
| 50–54 | 6744 (22.3) | 2607 (23.7) | 2039 (27.4) | 1506 (23.9) | 765 (17.0) | 947 (19.5) | 1099 (20.0) | 15,707 (22.5) | 75,756 (20.7) | 91,463 (21.0) |
| 55–64 | 13,703 (45.4) | 4853 (44.1) | 3414 (45.8) | 2707 (42.9) | 1805 (40.1) | 1895 (39.0) | 2316 (42.0) | 30,693 (44.0) | 162,606 (44.3) | 193,299 (44.3) |
| 65–74 | 9754 (32.3) | 3534 (32.1) | 2003 (26.9) | 2101 (33.3) | 1928 (42.9) | 2015 (41.5) | 2091 (38.0) | 23,426 (33.5) | 128,210 (35.0) | 151,636 (34.7) |
| Female | 17,410 (57.7) | 6172 (56.1) | 3817 (51.2) | 3152 (49.9) | 2531 (56.3) | 2957 (60.9) | 3013 (54.4) | 39,052 (55.9) | 187,039 (51.0) | 226,090 (51.8) |
| Membership, yearsa | 13.0 (10.7) | 12.9 (11.1) | 9.4 (8.7) | 11.4 (9.7) | 16.5 (13.5) | 11.0 (10.2) | 11.2 (10.2) | 12.4 (10.8) | 14.7 (11.5) | 14.4 (12.4) |
| English preferred | 27,779 (92.0) | 7872 (71.6) | 4758 (63.8) | 5653 (89.5) | 4174 (92.8) | 3143 (64.7) | 4103 (74.5) | 57482 (82.3) | 359,875 (98.2) | 417,357 (95.6) |
|
| ||||||||||
| <18.5 | 245 (0.8) | 364 (3.3) | 234 (3.1) | 76 (1.2) | 139 (3.1) | 129 (2.7) | 96 (1.7) | 1283 (1.8) | 3201 (0.9) | 4484 (1.0) |
| 18.5–24.9 | 11,246 (37.2) | 6362 (57.9) | 4668 (62.6) | 2601 (41.2) | 1969 (43.8) | 2874 (59.2) | 2599 (47.2) | 32,319 (46.3) | 90,671 (24.7) | 122,990 (28.2) |
| 25.0–29.9 | 13,381 (44.3) | 3335 (30.3) | 2164 (29.0) | 2663 (42.2) | 1593 (35.4) | 1554 (32.0) | 1830 (33.2) | 26,520 (38.0) | 131,772 (35.6) | 158,292 (36.3) |
| ≥30.0 | 5075 (16.8) | 770 (7.0) | 296 (4.0) | 928 (14.7) | 726 (16.1) | 248 (5.1) | 469 (8.5) | 8512 (12.2) | 134,661 (36.4) | 143,173 (32.8) |
| Missing | 254 (0.8) | 163 (1.5) | 94 (1.3) | 46 (0.7) | 71 (1.6) | 52 (1.1) | 512 (9.3) | 1192 (1.7) | 6267 (1.7) | 7459 (1.7) |
|
| ||||||||||
| 0 | 5791 (19.2) | 2694 (24.5) | 1488 (20.0) | 1318 (20.9) | 985 (21.9) | 826 (17.0) | 1510 (27.4) | 14,612 (20.9) | 106,287 (29.0) | 120,899 (27.7) |
| 1 | 4345 (14.4) | 1480 (13.5) | 920 (12.3) | 832 (13.2) | 529 (11.8) | 659 (13.6) | 735 (13.4) | 9500 (13.6) | 47,812 (13.0) | 57,312 (13.1) |
| 2 | 6499 (21.5) | 1958 (17.8) | 1421 (19.1) | 1272 (20.2) | 744 (16.5) | 960 (19.8) | 1075 (19.5) | 13,929 (20.0) | 63,206 (17.2) | 77,135 (17.2) |
| 3 | 13,566 (44.9) | 4862 (44.2) | 3627 (48.7) | 2892 (45.8) | 2240 (49.8) | 2412 (50.0) | 2186 (39.7) | 31,785 (45.5) | 149,267 (40.7) | 181,052 (41.5) |
aHealth plan membership duration prior to study entry
bInfluenza vaccination in the 3 years prior to study entry
Fig. 1Colorectal cancer screening participation and test usage among Asian subgroups, Asians overall, and non-Hispanic whites.
Fig. 2Adjusted prevalence ratios1,2 and 95% confidence intervals (CI) among Asian subgroups, Asians overall, and non-Hispanic whites.
1Reference group is non-Hispanic whites. 2Adjusted for age, sex, length of health plan membership prior to study entry, English language preference, body mass index, and number of influenza vaccines received in the 3 years before study entry